Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment.
Gomez-Cadena A, Spehner L, Kroemer M, Khelil MB, Bouiller K, Verdeil G, Trabanelli S, Borg C, Loyon R, Jandus C.
Gomez-Cadena A, et al. Among authors: khelil mb.
Cell Mol Immunol. 2021 Feb;18(2):484-486. doi: 10.1038/s41423-020-00596-2. Epub 2020 Dec 14.
Cell Mol Immunol. 2021.
PMID: 33318627
Free PMC article.
No abstract available.